BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23851503)

  • 1. Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.
    Huang CK; Yang CY; Jeng YM; Chen CL; Wu HH; Chang YC; Ma C; Kuo WH; Chang KJ; Shew JY; Lee WH
    Oncogene; 2014 Jun; 33(23):2968-77. PubMed ID: 23851503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.
    Wu HH; Hwang-Verslues WW; Lee WH; Huang CK; Wei PC; Chen CL; Shew JY; Lee EY; Jeng YM; Tien YW; Ma C; Lee WH
    J Exp Med; 2015 Mar; 212(3):333-49. PubMed ID: 25732306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance.
    Guo HZ; Niu LT; Qiang WT; Chen J; Wang J; Yang H; Zhang W; Zhu J; Yu SH
    FASEB J; 2019 Aug; 33(8):9565-9576. PubMed ID: 31136196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.
    Bie Q; Sun C; Gong A; Li C; Su Z; Zheng D; Ji X; Wu Y; Guo Q; Wang S; Xu H
    Sci Rep; 2016 May; 6():25447. PubMed ID: 27146881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines.
    Gelaleti GB; Borin TF; Maschio-Signorini LB; Moschetta MG; Jardim-Perassi BV; Calvinho GB; Facchini MC; Viloria-Petit AM; de Campos Zuccari DAP
    Life Sci; 2017 Aug; 183():98-109. PubMed ID: 28624391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer.
    Bastid J; Dejou C; Docquier A; Bonnefoy N
    Front Immunol; 2020; 11():718. PubMed ID: 32373132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
    Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F
    Breast Cancer Res Treat; 2011 Nov; 130(1):29-40. PubMed ID: 21153051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.
    Huang SC; Wei PC; Hwang-Verslues WW; Kuo WH; Jeng YM; Hu CM; Shew JY; Huang CS; Chang KJ; Lee EY; Lee WH
    EMBO Mol Med; 2017 Dec; 9(12):1660-1680. PubMed ID: 28993429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 Induces IL17Rb Gene Transcription in Monocytic Cells with Coordinate Autocrine IL-25 Signaling.
    Weathington NM; Kanth SM; Gong Q; Londino J; Hoji A; Rojas M; Trudeau J; Wenzel S; Mallampalli RK
    Am J Respir Cell Mol Biol; 2017 Sep; 57(3):346-354. PubMed ID: 28421819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination.
    Bie Q; Song H; Chen X; Yang X; Shi S; Zhang L; Zhao R; Wei L; Zhang B; Xiong H; Zhang B
    Oncogene; 2021 Mar; 40(12):2200-2216. PubMed ID: 33649532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positive feedback loop of IL-17B-IL-17RB activates ERK/β-catenin to promote lung cancer metastasis.
    Yang YF; Lee YC; Lo S; Chung YN; Hsieh YC; Chiu WC; Yuan SF
    Cancer Lett; 2018 May; 422():44-55. PubMed ID: 29496538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression.
    Ren L; Xu Y; Liu C; Wang S; Qin G
    Mol Immunol; 2017 Oct; 90():126-135. PubMed ID: 28715683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
    O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.